184 related articles for article (PubMed ID: 37786778)
1. Inactivation of TRPM7 Kinase Targets AKT Signaling and Cyclooxygenase-2 Expression in Human CML Cells.
Hoeger B; Nadolni W; Hampe S; Hoelting K; Fraticelli M; Zaborsky N; Madlmayr A; Sperrer V; Fraticelli L; Addington L; Steinritz D; Chubanov V; Geisberger R; Greil R; Breit A; Boekhoff I; Gudermann T; Zierler S
Function (Oxf); 2023; 4(6):zqad053. PubMed ID: 37786778
[TBL] [Abstract][Full Text] [Related]
2. TRPM7 Kinase Is Essential for Neutrophil Recruitment and Function
Nadolni W; Immler R; Hoelting K; Fraticelli M; Ripphahn M; Rothmiller S; Matsushita M; Boekhoff I; Gudermann T; Sperandio M; Zierler S
Front Immunol; 2020; 11():606893. PubMed ID: 33658993
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.
Ha YS; Kim YY; Yu NH; Chun SY; Choi SH; Lee JN; Kim BS; Yoo ES; Kwon TG
Investig Clin Urol; 2018 Jul; 59(4):263-274. PubMed ID: 29984342
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domain.
Yogi A; Callera GE; O'Connor S; Antunes TT; Valinsky W; Miquel P; Montezano AC; Perraud AL; Schmitz C; Shrier A; Touyz RM
Cell Signal; 2013 Nov; 25(11):2163-75. PubMed ID: 23838006
[TBL] [Abstract][Full Text] [Related]
5. TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma.
Zhao Z; Zhang M; Duan X; Chen Y; Li E; Luo L; Wu W; Peng Z; Qiu H; Zeng G
Mol Cancer Res; 2018 Jun; 16(6):1013-1023. PubMed ID: 29545479
[TBL] [Abstract][Full Text] [Related]
6. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
7. TRPM6 kinase activity regulates TRPM7 trafficking and inhibits cellular growth under hypomagnesic conditions.
Brandao K; Deason-Towne F; Zhao X; Perraud AL; Schmitz C
Cell Mol Life Sci; 2014 Dec; 71(24):4853-67. PubMed ID: 24858416
[TBL] [Abstract][Full Text] [Related]
8. Silencing TRPM7 in mouse cortical astrocytes impairs cell proliferation and migration via ERK and JNK signaling pathways.
Zeng Z; Leng T; Feng X; Sun H; Inoue K; Zhu L; Xiong ZG
PLoS One; 2015; 10(3):e0119912. PubMed ID: 25799367
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.
Lee EH; Chun SY; Kim B; Yoon BH; Lee JN; Kim BS; Yoo ES; Lee S; Song PH; Kwon TG; Ha YS
BMC Urol; 2020 Sep; 20(1):145. PubMed ID: 32907556
[TBL] [Abstract][Full Text] [Related]
10. Propofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression.
Tan Z; Peng A; Xu J; Ouyang M
BMC Anesthesiol; 2017 Sep; 17(1):132. PubMed ID: 28962554
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.
Zhou W; Guo S; Xiong Z; Liu M
Expert Opin Ther Targets; 2014 Oct; 18(10):1177-96. PubMed ID: 25069584
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Akt kinase in the action of STI571 on chronic myelogenous leukemia cells.
Kawauchi K; Ogasawara T; Yasuyama M; Ohkawa Si
Blood Cells Mol Dis; 2003; 31(1):11-7. PubMed ID: 12850478
[TBL] [Abstract][Full Text] [Related]
13. Local Anesthetic Drug Inhibits Growth and Survival in Chronic Myeloid Leukemia Through Suppressing PI3K/Akt/mTOR.
Zheng Q; Peng X; Yu H
Am J Med Sci; 2018 Mar; 355(3):266-273. PubMed ID: 29549929
[TBL] [Abstract][Full Text] [Related]
14. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.
Fang L; Zhan S; Huang C; Cheng X; Lv X; Si H; Li J
Toxicol Appl Pharmacol; 2013 Nov; 272(3):713-25. PubMed ID: 23958495
[TBL] [Abstract][Full Text] [Related]
15. A Biodegradable Mg-Based Alloy Inhibited the Inflammatory Response of THP-1 Cell-Derived Macrophages Through the TRPM7-PI3K-AKT1 Signaling Axis.
Jin L; Chen C; Li Y; Yuan F; Gong R; Wu J; Zhang H; Kang B; Yuan G; Zeng H; Chen T
Front Immunol; 2019; 10():2798. PubMed ID: 31849975
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
Weisberg E; Banerji L; Wright RD; Barrett R; Ray A; Moreno D; Catley L; Jiang J; Hall-Meyers E; Sauveur-Michel M; Stone R; Galinsky I; Fox E; Kung AL; Griffin JD
Blood; 2008 Apr; 111(7):3723-34. PubMed ID: 18184863
[TBL] [Abstract][Full Text] [Related]
17. EPS8 regulates proliferation, apoptosis and chemosensitivity in BCR-ABL positive cells via the BCR-ABL/PI3K/AKT/mTOR pathway.
Huang R; Liu H; Chen Y; He Y; Kang Q; Tu S; He Y; Zhou X; Wang L; Yang J; Wu A; Li Y
Oncol Rep; 2018 Jan; 39(1):119-128. PubMed ID: 29192326
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Transient Receptor Potential Melastain 7 Enhances Apoptosis Induced by TRAIL in PC-3 cells.
Lin CM; Ma JM; Zhang L; Hao ZY; Zhou J; Zhou ZY; Shi HQ; Zhang YF; Shao EM; Liang CZ
Asian Pac J Cancer Prev; 2015; 16(10):4469-75. PubMed ID: 26028116
[TBL] [Abstract][Full Text] [Related]
19. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
20. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
